Medicines Co (MDCO) Posts Stronger Q1 adj.-EPS of 33c
Get Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Research and development: 23.54M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Research and development: 23.54M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $177.2 million versus the consensus estimate of $175.6 million.
Adjusted net income(1) for the first quarter of 2014 increased 25% to $22.1 million, or $0.33 per share(1), compared to adjusted net income(1) of $17.7 million, or $0.31 per share(1) for the first quarter 2013.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c
- TechnipFMC (FTI) PT Raised to $30 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!